American Heart Journal
Volume 144, Issue 3 , Pages 538-543 , September 2002

Impact of disease activity on left ventricular performance in patients with acromegaly

Received 4 September 2001 ,Accepted 23 January 2002.

References 

  1. Nabarro JD. Acromegaly. Clin Endocrinol (Oxf). 1987;26:481–512
  2. Bengtsson B, Eden S, Ernest I, et al.  Epiodemiology and long-term survival in acromegaly. Acta Med Scand. 1988;223:327–335
  3. Hayward RP, Emanuel RW, Nabarro JD. Acromegalic heart disease: influence of treatment of the acromegaly on the heart. Q J Med. 1987;62:41–58
  4. Morvan D, Komajda M, Grimaldi A, et al.  Cardiac hypertrophy and function in asymptomatic acromegaly. Eur Heart J. 1991;12:666–672
  5. Lopez-Velasco R, Escobar-Morreale HF, Vega B, et al.  Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension. J Clin Endocrinol Metabol. 1997;82:1047–1053
  6. Colao A, Cuocolo A, Marzullo P, et al.  Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiographic study. J Clin Endocrinol Metabol. 1999;84:1518–1526
  7. Giustina A, Boni E, Romanelli G, et al.  Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol. 1995;75:1042–1047
  8. Seely EW, Williams GH. The cardiovascular system and endocrine disease. In:  Becker KL editors. Principles and practice of endocrinology and metabolism. Philadelphia: : Lipincott; 1990;p. 1496–1503
  9. Colao A, Merola B, Ferone D, et al.  Acromegaly. J Clin Endocrinol Metabol. 1997;82:2777–2781
  10. Thuesen L, Christensen SE, Weeke J, et al.  The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin Endocrinol. 1989;30:619–625
  11. Merola B, Cittadini A, Colao A, et al.  Chronic treatment with somatostatin analog octrotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metabol. 1993;77:790–793
  12. Pereira JL, Rodriguez-Puras MJ, Leal-Cerro A, et al.  Acromegalic cardiopathy improves with increasing doses of octreotide. J Endocrinol Invest. 1991;14:17–23
  13. Nagueh SF, Middleton KJ, Kopelen HA, et al.  Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527–1533
  14. Rodriguez L, Garcia M, Ares M, et al.  Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J. 1996;131:982–987
  15. Sohn DW, Chai ICH, Lee DJ, et al.  Assessment of mitral anulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474–480
  16. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:396–404
  17. Tei C, Dujardin KS, Hodge DO, et al.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996;28:658–664
  18. Bruch C, Schmermund A, Marin D, et al.  Tei-index in patients with mild to moderate congestive heart failure. Eur Heart J. 2000;21:1888–1895
  19. Guidelines Subcommittee: World Health Organization . International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151–184
  20. World Health Organization . Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: : World Health Organization; 1999;
  21. Giustina A, Barkan A, Casanueva FF, et al.  Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metabol. 2000;85:526–529
  22. Rakowski H, Appleton C, Chan KL, et al.  Canadian consensus recommendations for measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr. 1996;9:736–760
  23. Tenenbaum A, Motro M, Hod H, et al.  Shortened Doppler-derived mitral A wave deceleration time: an important predictor of elevated left ventricular filling pressure. Z J Am Coll Cardiol. 1996;27:700–705
  24. Griner PF, Mayewski RJ, Mushlin AI, et al.  Selection of diagnostic tests and procedures. Ann Intern Med. 1981;94:555–600
  25. Sacca L, Cittadini A, Fazio F. Growth hormone and the heart. Endocr Rev. 1994;15:555–573
  26. Minniti G, Jaffrain-Rea ML, Moroni C, et al.  Echocardiographic evidence for a direct effect of GH/IGF-1 hypersecretion on cardiac mass and function in young acromegalics. Clin Endocrinol (Oxf). 1998;49:101–106
  27. Mercuro G, Zoncu S, Colonna P, et al.  Cardiac dysfunction in acromegaly: evidence by pulsed wave tissue Doppler imaging. Eur J Endocrinol. 2000;143:363–369

☆ Reprint requests: Christian Bruch, WWU Muenster, Innere Medizin C, Albert-Schweitzer-Str. 33, 48129 Muenster, Germany.

☆☆ E-mail: bruchc@uni-muenster.de

PII: S0002-8703(02)00120-5

doi: 10.1067/mhj.2002.123572

American Heart Journal
Volume 144, Issue 3 , Pages 538-543 , September 2002

Article Tools

* Image Usage & Resolution